Literature DB >> 7738245

Staphylococci in heifer mastitis before and after parturition.

V Myllys1.   

Abstract

Aseptic udder quarter secretion samples (n = 1112) from 200 mastitic and 65 non-mastitic control heifers from 160 different farms were collected for bacteriological examination and in vitro antimicrobial susceptibility testing. Coagulase-negative staphylococci (CNS) were the most frequently isolated bacteria (57.8%). The percentage of Staphylococcus aureus was 20.1, of streptococci 11.3 and of other pathogens 10.8. Staph. simulans, Staph. hyicus, Staph. xylosus and Staph. chromogenes were the most common CNS. Staph. simulans and Staph. hyicus were most frequently found in clinical samples after parturition, whereas other CNS were equally or more often found in control samples. Most CNS infections detected in the prepartum period were eliminated spontaneously or with antibiotic treatment during early lactation, but the infected quarters were more susceptible to new infection by other pathogens. Milk N-acetyl-beta-glucosaminidase activities were measured to monitor changes in inflammation. Among the CNS infections, N-acetyl-beta-glucosaminidase activities were highest for Staph. hyicus and lowest for Staph. xylosus in the lactating mammary gland of heifers. CNS were resistant to trimethoprim-sulphonamide, ampicillin and erythromycin. Staph. aureus was more resistant than CNS to beta-lactamase-sensitive penicillins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7738245     DOI: 10.1017/s0022029900033665

Source DB:  PubMed          Journal:  J Dairy Res        ISSN: 0022-0299            Impact factor:   1.904


  9 in total

1.  Cytotoxic activity of coagulase-negative staphylococci in bovine mastitis.

Authors:  S Zhang; C W Maddox
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Widespread distribution of disinfectant resistance genes among staphylococci of bovine and caprine origin in Norway.

Authors:  Jostein Bjorland; Terje Steinum; Bjørg Kvitle; Steinar Waage; Marianne Sunde; Even Heir
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Application of pulsed-field gel electrophoresis and binary typing as tools in veterinary clinical microbiology and molecular epidemiologic analysis of bovine and human Staphylococcus aureus isolates.

Authors:  R Zadoks; W van Leeuwen; H Barkema; O Sampimon; H Verbrugh; Y H Schukken; A van Belkum
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

4.  Effect of precalving intramammary treatment with pirlimycin in nulliparous Holstein heifers.

Authors:  Jean-Philippe Roy; Denis Du Tremblay; Luc DesCôteaux; Serge Messier; Daniel Scholl; Emile Bouchard
Journal:  Can J Vet Res       Date:  2007-10       Impact factor: 1.310

5.  Occurrence of clinical mastitis in primiparous Estonian dairy cows in different housing conditions.

Authors:  Piret Kalmus; Arvo Viltrop; Birgit Aasmäe; Kalle Kask
Journal:  Acta Vet Scand       Date:  2006-11-21       Impact factor: 1.695

6.  Bovine-associated CNS species resist phagocytosis differently.

Authors:  Silja Avall-Jääskeläinen; Joanna Koort; Heli Simojoki; Suvi Taponen
Journal:  BMC Vet Res       Date:  2013-11-11       Impact factor: 2.741

7.  Effects of Pre-Parturient Iodine Teat Dip Applications on Modulating Aversive Behaviors and Mastitis in Primiparous Cows.

Authors:  Hannah N Phillips; Ulrike S Sorge; Bradley J Heins
Journal:  Animals (Basel)       Date:  2021-05-31       Impact factor: 2.752

8.  Host adapted intramammary infections in pregnant heifers which were co-housed and reared on fresh milk as calves.

Authors:  Inge-Marié Petzer; Joanne Karzis; Maia Lesosky; Johanna C Watermeyer; Renette Badenhorst
Journal:  BMC Vet Res       Date:  2013-03-15       Impact factor: 2.741

9.  Comparative genome analysis of 24 bovine-associated Staphylococcus isolates with special focus on the putative virulence genes.

Authors:  Suvi Taponen; Ravi Kant; Airi Palva; Joanna Koort; Silja Åvall-Jääskeläinen; Lars Paulin; Jochen Blom
Journal:  PeerJ       Date:  2018-03-30       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.